Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00125437
Recruitment Status : Terminated (Poor compliance with the therapy and lot of patients were lost to follow up.)
First Posted : August 1, 2005
Last Update Posted : July 15, 2009
Information provided by:
Hebei Medical University

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Estimated Study Completion Date : September 2009